newsfilter
← Latest News
GlobeNewswire·

Results of General Meeting

Results of General Meeting Share-Repurchase Program Form of Contract and Counterparties Approved DUBLIN, Ireland, and Boston MA, March 3, 2022, Amryt (NASDAQ:AMYT), a global, commercial-stage biopharmaceutical company focussed on acquiring, develo